16 August 2025
: Case report 
Successful Treatment of Multidrug-Resistant Tuberculous Meningitis in a Young Chinese Woman: A Case Study From Japan
Unusual clinical course, Unusual setting of medical care
Michiho Tanaka
EF 1*, Ryo Hasegawa EF 2, Kazuhiro Ishikawa EF 1, Nobuyoshi Mori AEF 1
DOI: 10.12659/AJCR.947502
Am J Case Rep 2025; 26:e947502
Table 1 Results of the drug susceptibility test using Brosmic MTB®, (Kyokuto pharmaceutical INC, Tokyo, Japan).
| Drug | MIC | Sensitivity |
|---|---|---|
| SM | >128 | R |
| INH | 8 | R |
| RFP | >32 | R |
| EB | 16 | R |
| LVFX | 0.5 | S |
| RBT | 4 | R |
| PZA | / | S |
| Breakpoints are from the Clinical and Laboratory Standards Institute. EB – ethambutol; INH – isoniazid; LVFX – levofloxacin; MIC – minimum inhibitory concentrations; PZA – pyrazinamide; R – resistant; RFP – rifampicin; RBT – rifabutin; S – susceptible; SM – streptomycin. | ||